August 23, 2012
A Virginia federal judge on Wednesday preserved Exela Pharma Sciences LLC's lawsuit alleging the federal government improperly revived a patent related to injectable acetaminophen treatment Ofirmev, a significant victory as the company defends itself in a separate patent infringement case.